Modulation of the Activity of ABC Transporters (P-Glycoprotein, MRP2, BCRP) by Flavonoids and Drug Response

被引:179
作者
Alvarez, Ana I. [1 ]
Real, Rebeca [1 ]
Perez, Miriam [1 ]
Mendoza, Gracia [1 ]
Prieto, Julio G. [1 ]
Merino, Gracia [2 ]
机构
[1] Univ Leon, Fac Vet, Dept Ciencias Biomed, Area Fisiol, E-24071 Leon, Spain
[2] Univ Leon, Inst Desarrollo Ganadero & Sanidad Anim, E-24071 Leon, Spain
关键词
flavonoids; ABC transporters; P-glycoprotein/ABCB1; MRP2/ABCC2; BCRP/ABCG2; drug interaction; CANCER RESISTANCE PROTEIN; PERFUSED RAT-LIVER; MULTIDRUG-RESISTANCE; INTESTINAL-ABSORPTION; GRAPEFRUIT JUICE; ORAL BIOAVAILABILITY; MEDIATED INHIBITION; DIETARY FLAVONOIDS; BINDING SITES; CACO-2; CELLS;
D O I
10.1002/jps.21851
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present article aims to review the up-to-date information on the most recent studies of the interaction of flavonoids with ABC transporters, in particular the drug pharmacokinetic consequences of such a relationship. In addition, the modulation of the expression of the ABC transporters by flavonoids is also illustrated. Flavonoids are a large group of plant polyphenols present extensively in our daily diets and herbal products. High intake of isoflavones has been associated with a variety of beneficial effects on several common diseases. These polyphenols interact with ABC drug transporters involved in drug resistance and drug absorption, distribution and excretion. A number of studies have demonstrated inhibition of drug transporters by flavonoids. This flavonoid-ABC-transporter interaction could be beneficial for poorly absorbed drugs but could also result in severe drug intoxication, especially drugs with a narrow therapeutic window. On the other hand, flavonoids are themselves substrates of ABC transporters. These proteins can affect the oral availability and tissue distribution of these compounds, modifying their beneficial effects. The challenge is to find a suitable way to predict harmful drug-flavonoid interactions mediated by these transporters. (C) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:598-617, 2010
引用
收藏
页码:598 / 617
页数:20
相关论文
共 50 条
  • [41] Modulation of Expression and Activity of ABC Transporters by the Phytoestrogen Genistein. Impact on Drug Disposition
    Pablo Rigalli, Juan
    Ciriaci, Nadia
    Domingo Mottino, Aldo
    Alicia Catania, Viviana
    Laura Ruiz, Maria
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (13) : 1370 - 1389
  • [42] Expression of multidrug transporters MRP1, MRP2, and BCRP shortly after status epilepticus, during the latent period, and in chronic epileptic rats
    van Vliet, EA
    Redeker, S
    Aronica, E
    Edelbroek, PM
    Gorter, JA
    EPILEPSIA, 2005, 46 (10) : 1569 - 1580
  • [43] Study Models of Drug-Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels
    Veiga-Matos, Jessica
    Morales, Ana I.
    Prieto, Marta
    Remiao, Fernando
    Silva, Renata
    MOLECULES, 2023, 28 (22):
  • [44] Dual inhibitors of the human blood-brain barrier drug efflux transporters P-glycoprotein and ABCG2 based on the antiviral azidothymidine
    Namanja-Magliano, Hilda A.
    Bohn, Kelsey
    Agrawal, Neha
    Willoughby, Meghan E.
    Hrycyna, Christine A.
    Chmielewski, Jean
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (19) : 5128 - 5132
  • [45] Self-emulsifying drug-delivery systems modulate P-glycoprotein activity: role of excipients and formulation aspects
    AboulFotouh, Khaled
    Allam, Ayat A.
    El-Badry, Mahmoud
    El-Sayed, Ahmed M.
    NANOMEDICINE, 2018, 13 (14) : 1813 - 1834
  • [46] Upregulation of the expression of endogenous Mdr1 P-glycoprotein enhances lipid translocation in MDCK cells transfected with human MRP2
    Raggers, RJ
    Vogels, I
    van Meer, G
    HISTOCHEMISTRY AND CELL BIOLOGY, 2002, 117 (02) : 181 - 185
  • [47] Temporal/spatial expression and efflux activity of ABC transporter, P-glycoprotein/Abcb1 isoforms and Bcrp/Abcg2 during early murine development
    Sawicki, Wojciech T.
    Kujawa, Marek
    Jankowska-Steifer, Ewa
    Mystkowska, Ewa T.
    Hyc, Anna
    Kowalewski, Cezary
    GENE EXPRESSION PATTERNS, 2006, 6 (07) : 738 - 746
  • [48] Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma
    Kanwar, Jagat R.
    Singh, Neha
    Kanwar, Rupinder K.
    NANOMEDICINE, 2011, 6 (04) : 701 - 714
  • [49] Lipid environment determines the drug-stimulated ATPase activity of P-glycoprotein
    Tran, Nghi N. B.
    Bui, A. T. A.
    Jaramillo-Martinez, Valeria
    Weber, Joachim
    Zhang, Qinghai
    Urbatsch, Ina L.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [50] Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells
    Nieri, P
    Romiti, N
    Adinolfi, B
    Chicca, A
    Massarelli, I
    Chieli, E
    BRITISH JOURNAL OF PHARMACOLOGY, 2006, 148 (05) : 682 - 687